TALi Digital appoints Dr Mary Elizabeth Brinson as interim Chief Executive Officer

SYDNEY: TALi Digital Ltd announced the appointment of Dr Mary Elizabeth Brinson as Interim Chief Executive Officer in addition to her role as Chief Medical Officer.

Dr Brinson was former Vice President, Global Clinical Affairs, with medical devices leader Cochlear Limited (ASX: COH).

Mary Beth holds a Doctorate in Audiology from the University of Louisville in Kentucky, a Master of Business Administration from Rutgers University in New Jersey and a bachelor’s degree in Audiology and Speech Pathology from the University of Georgia in the United States.

Mary Beth has held a number of senior roles during a 16-year career at Cochlear including Director of Quality, Clinical and Regulatory Services and Director of Clinical Services, Research and Professional Training. She is a qualified Audiologist and has practiced in healthcare and academia in the U.S. and United Kingdom. She is also an Adjunct Fellow at Macquarie University in Sydney.

“We’re thrilled that Mary Beth has agreed to step up to the role on Interim Chief Executive Officer in addition to her role as Chief Medical Officer,” said TAli Chair Sue MacLeman.

“The Board and Executive have been working on a full operational review of the business and Mary Beth’s background and leadership provides an excellent foundation for supporting the TALi corporate mission to bring the benefits of strong attention to young children. Her experience leading teams at Cochlear, one of the world’s most successful medical devices businesses, will be invaluable as we work to make the benefits of TALi’s innovative digital therapeutic available to patients.”

Her appointment in this new combined role takes effect 27th April 2022.

TALi Digital Limited (ASX: TD1) is a digital health company delivering diagnostic and therapeutic solutions to enhance cognitive function and behaviour. The Company has built a patented platform technology with our first solution targeting cognitive attention skills during early childhood via the evidence-based screening (DETECT®) and training (TRAIN®) modules.

This program is complementary to existing diagnosis and therapy, placing TALi at the forefront of improving early intervention for childhood attention and concentration performance. www.talidigital.com

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *